Search

You searched for "eye examination"

993 results found

Ocular neuromyotonia features

1 August 2019 | | EYE - Paediatrics, EYE - Strabismus
The authors present eight cases of ocular neuromyotonia (ONM) with an overview of the pathophysiology, aetiology, clinical presentations and possible treatments. Diagnosis was made only after thorough and repeated orthoptic examinations and review of medication history. An overview of the...

ROP screening criteria

7 April 2021 | | EYE - Paediatrics, EYE - Strabismus
This study aimed to describe a process of identifying birth weight and gestational age screening guidelines in Mongolia using telemedicine for retinopathy of prematurity (ROP) screening. This was a single centre prospective study collecting data from December 2016 to January...
Neuro-Ophthalmology journal cover image

ROPPVAL Syndrome as a differential diagnosis to optic neuritis

1 December 2021 | | EYE - Neuro-ophthalmology | Photophobia, ROPPVAL, headache, migraine, optic neuritis, retro-ocular pain
Optic neuritis (ON) is a common cause of visual loss in young patients. Patients with eye pain and ipsilateral visual loss are often referred into neuro-ophthalmology clinics with a possible diagnosis of ON. In 2018 Jefferis et al. reported a...
Pediatric Ophthalmology & Strabismus journal cover

Optic canal measurements in children

5 August 2022 | | EYE - Paediatrics, EYE - Strabismus
The authors aimed to determine the normal range of optic canal diameters in a Turkish pediatric population. They evaluated 200 CT examinations: 102 females, 98 males with mean age of 86.42 ±65.39 months (range 1-211). There was no significant difference...

Ocular motility parameters in phakic and pseudophakic older people

4 October 2023 | | EYE - Paediatrics, EYE - Strabismus
The aim of this study was to compare the extent of phoria, strabismus and convergence of pseudophakic vs phakic people in an elderly population. The study was part of the Tehran Geriatric Eye Study (TGES). Of 3791 invitees, 3310 participated...

Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment

1 February 2015 | | EYE - Vitreo-Retinal, EYE - General
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...

Lockdown and eye health – a case of accommodative spasm

6 April 2021 | | EYE - Orbit, EYE - Imaging, EYE - General
A 25-year-old male presented to the eye casualty with a one-day history of sudden onset worsening vision. More specifically, he noted his vision was more blurred than usual and this was more exaggerated for near-work than for distance-work. He was...

Microcatheter in the vertebral artery as a cause of branched retinal artery occlusion?

4 August 2021 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
A 19-year-old male presented to eye casualty with a seven-day history of a ‘blurred patch’ in the left eye. The patient denied any other visual symptoms including flashes or floaters and there had been no change in visual symptoms in...

Getting the Duke Elder examination right: reflections and tips from a medical student

31 May 2023 | | EYE - General
The Duke Elder undergraduate prize examination is an annual exam organised by the Royal College of Ophthalmologists in the United Kingdom. Named after Sir Stewart Duke Elder, a prominent British ophthalmologist, the exam is designed to encourage undergraduate medical students...

The eye without tears

1 June 2016 | | EYE - General
The Art is long and Life is short. So goes the dispiriting tag in Latin and flung from day one and at regular intervals thereafter at idle medical students who, inevitably brainwashed, come by graduation to believe that the only...

Booster accelerates EU-funded projects results to create tangible impact

2 December 2024 | EU-funded research, Dissemination, Exploitation, Commercialisation, Research exploitation, Horizon Europe programme, Impact, Research & Innovation, DG RTD
META Group is proud to announce that Booster has been renewed for another four years, with additional and customised services. Funded by the European Commission’s Directorate-General for Research and Innovation (DG RTD) and led by META Group, Booster offers a...

Contemporary glaucoma therapy: spoilt for choice

1 April 2014 | | EYE - Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...